Ifetroban

DB12321InvestigationalSmall molecule

Ifetroban has been used in trials studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and Scleroderma, Diffuse, among others.

Formula / weight: C₂₅H₃₂N₂O₅ · 440.54 g/mol (avg)
Code names: BMS-180291

Resolves to

Compound

UNIIE833KT807KCAS143443-90-7ChEMBLCHEMBL3301673PubChem3037233

Structure

InChIKeyBBPRUNPUJIUXSE-DXKRWKNPSA-NSMILESCCCCCNC(=O)C1=COC(=N1)[C@@H]1[C@H]2CC[C@H](O2)[C@@H]1CC1=CC=CC=C1CCC(O)=O

Targets

P21731TBXA2R

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

420Drug interactionsStructured to mechanism, not free text

10Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Ifetroban, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account